New diabetes clinical trial: Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus

Published on: June 04, 2019 at 09:30PM
Condition:   Type2 Diabetes Mellitus
Interventions:   Drug: glucokinase activator;   Drug: Placebo
Sponsor:   PegBio Co., Ltd.
Not yet recruiting
http://bit.ly/2MrwFQt